stellabeta Find trials matched to me Trial Match

Clinical trials for

Recurrent Hepatocellular Carcinoma

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RecruitingObservational

Phoenix, Arizona, United States +2 moreCheck eligibility →

RecruitingSafety & dosing

Xiangyang, Hubei, China +1 moreCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, China +4 moreCheck eligibility →

RecruitingSafety & dosing

Jinan, Shandong, ChinaCheck eligibility →

RecruitingTesting a treatment

Bay City, Michigan, United States +4 moreCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingPost-approval monitoring

New York, New York, United States +4 moreCheck eligibility →

RecruitingTesting a treatment

Changsha, Hunan, ChinaCheck eligibility →

RecruitingTesting a treatment

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingObservational

Wuhan, Hubei, ChinaCheck eligibility →

RecruitingTesting a treatment

Rouen, FranceCheck eligibility →

RecruitingVery early testing

Beijing, Beijing Municipality, China +1 moreCheck eligibility →

RecruitingSafety & dosing

New York, New York, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Fuyang, Anhui, China +1 moreCheck eligibility →

RecruitingObservational

Wuhan, Hubei, ChinaCheck eligibility →

RecruitingSafety & dosing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingTesting a treatment

Lisbon, PortugalCheck eligibility →

RecruitingSafety & dosing

Hefei, Anhui, ChinaCheck eligibility →

RecruitingSafety & dosing

Yangzhou, Jiangsu, ChinaCheck eligibility →

60

Trials actively recruiting for Recurrent Hepatocellular Carcinoma

RecruitingObservational

Phoenix, Arizona, United States +2 moreCheck eligibility →

RecruitingSafety & dosing

Xiangyang, Hubei, China +1 moreCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, China +4 moreCheck eligibility →

RecruitingSafety & dosing

Jinan, Shandong, ChinaCheck eligibility →

RecruitingTesting a treatment

Bay City, Michigan, United States +4 moreCheck eligibility →

RecruitingObservational

Guangzhou, Guangdong, ChinaCheck eligibility →

RecruitingPost-approval monitoring

New York, New York, United States +4 moreCheck eligibility →

RecruitingTesting a treatment

Changsha, Hunan, ChinaCheck eligibility →

RecruitingTesting a treatment

Beijing, Beijing Municipality, ChinaCheck eligibility →

RecruitingObservational

Wuhan, Hubei, ChinaCheck eligibility →

RecruitingTesting a treatment

Rouen, FranceCheck eligibility →

RecruitingVery early testing

Beijing, Beijing Municipality, China +1 moreCheck eligibility →

RecruitingSafety & dosing

New York, New York, United States +4 moreCheck eligibility →

RecruitingSafety & dosing

Fuyang, Anhui, China +1 moreCheck eligibility →

RecruitingObservational

Wuhan, Hubei, ChinaCheck eligibility →

RecruitingSafety & dosing

Hangzhou, Zhejiang, ChinaCheck eligibility →

RecruitingTesting a treatment

Lisbon, PortugalCheck eligibility →

RecruitingSafety & dosing

Hefei, Anhui, ChinaCheck eligibility →

RecruitingSafety & dosing

Yangzhou, Jiangsu, ChinaCheck eligibility →

60 trials · Recruiting

Trial status

Phase

Location